Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates real-time imaging of nitroxyl dynamics during ferroptosis-driven liver injury, indicating new pathways for early diagnosis.
As a global health challenge, drug-induced liver injury (DILI) is an acute inflammatory disease closely linked to ferroptosis. Ferroptosis, characterized by iron-dependent lipid peroxidation, has been implicated in diverse pathological conditions, however, its precise molecular mechanism in liver injury remains to be fully elucidated. As a key active nitrogen species, the concentration fluctuation of nitroxyl (HNO) is closely correlated with ferroptosis. Nevertheless, in situ and real-time monitoring of endogenous HNO remains highly challenging owing to its transient lifespan and prominent reactivity. To address this issue, we constructed a near-infrared fluorescent probe specifically activated by HNO to delineate the intrinsic interplay between ferroptosis and DILI, thereby facilitating early diagnosis. This probe features a rapid response rate, extremely specificity, high sensitivity, and outstanding photostability, successfully achieving precise detection and imaging of both exogenous and endogenous HNO in vitro and in vivo. Crucially, real-time monitoring of the dynamic fluctuations of HNO levels with the probe explicitly unveiled a tight correlation of the ferroptosis process with DILI. Notably, inhibiting ferroptosis could significantly alleviate the progression of liver injury. Overall, this work not only provides a powerful molecular tool for the diagnosis of ferroptosis-associated liver diseases, but also offers important theoretical foundations and new strategies for the early clinical intervention of liver injury and related drug screening.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: